# The Preoperative Administration of ICG Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.

> **NCT06398028** · PHASE4 · RECRUITING · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 173 (estimated)

## Conditions studied

- Liver Tumor; Surgery

## Interventions

- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT06398028
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-19
- **Primary completion:** 2026-03-19
- **Final completion:** 2028-03-19
- **Target enrollment:** 173 (ESTIMATED)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06398028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06398028, "The Preoperative Administration of ICG Improves Tumor Detection in Patients Undergoing Minimally Invasive Hepatic Resection Guided by Conventional Intraoperative Ultrasound.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06398028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*